Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Corcept Therapeutics's interest expense for the
three
months ended in Dec. 2020 was $ 0.0 Mil.
Its interest expense for the trailing twelve months (TTM) ended in Dec. 2020 was $0.0 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Corcept Therapeutics's Operating Income for the
three
months ended in Dec. 2020 was $ 30.5 Mil. Corcept Therapeutics's Interest Expense for the
three
months ended in Dec. 2020 was $ 0.0 Mil.
GuruFocus does not calculate Corcept Therapeutics's interest coverage with the available data.
The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Corcept Therapeutics Interest Expense Calculation
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Dec. 2020 was 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) + 0 (Dec. 2020 ) = $0.0 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
Corcept Therapeutics (NAS:CORT) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Corcept Therapeutics's Interest Expense for the
three
months ended in Dec. 2020 was $0.0 Mil. Its
Operating Income
for the
three
months ended in Dec. 2020 was $30.5 Mil. And its Long-Term Debt & Capital Lease Obligation for the
three
months ended in Dec. 2020 was $0.5 Mil.
Corcept Therapeutics's Interest Coverage for the quarter that ended in Dec. 2020 is calculated as
| GuruFocus does not calculate Corcept Therapeutics's interest coverage with the available data. |
* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies interest coverage is at least 5. Corcept Therapeutics Inc has enough cash to cover all of its debt. Its financial situation is stable.
Corcept Therapeutics Interest Expense Headlines
Excel Add-In GURUF
API
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
My Gurus
0.18(0.76%) Volume: 412,977 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Manual of Stocks™ Web APP
NAS:CORT has been successfully added to your 
